The mechanisms underlying the antidiabetic effect of ASE may involve the reduction of hyperinsulinemia, activation of insulin-signaling in muscle and adipose tissue, elevation of GLP-1 levels, and an anti-inflammatory property that contribute to the improvement of insulin sensitivity and therefore to glucose-lowering. The gene discussed is INS; the disease is hyperinsulinism.